Work

Patients with undetectable PSA 2 years after docetaxel for metastatic castration sensitive prostate cancer (mCSPC).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.e17044

Authors: Mohammad O. Atiq, Shruti Gandhy, Fatima Karzai, Marijo Bilusic, Lisa M. Cordes, Helen Owens, Anna Couvillon, Amy Hankin, Monique Williams, William Douglas Figg, William L. Dahut, James L. Gulley, Ravi Amrit Madan

Institutions: National Cancer Institute, National Institutes of Health

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3167779462

Cites:

Cited by: 1

Related to: 10